{"news_desk": "Business", "print_page": null, "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By MICHAEL J. de la MERCED", "person": [{"middlename": "J.", "firstname": "Michael", "lastname": "de la MERCED", "rank": 1, "role": "reported", "organization": ""}]}, "abstract": null, "type_of_material": "News", "word_count": "687", "lead_paragraph": "I.S.S., an influential advisory firm, recommends that investors vote down the drug maker\u2019s pursuit, but a hedge fund with a stake in Mylan supports the merger.", "pub_date": "2015-08-15T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Mylan\u2019s Bid to Buy Perrigo Is Complicated by Opposing Declarations"}, "snippet": "I.S.S., an influential advisory firm, recommends that investors vote down the drug maker\u2019s pursuit, but a hedge fund with a stake in Mylan supports the merger.", "multimedia": [], "web_url": "http://www.nytimes.com/2015/08/15/business/dealbook/mylans-bid-to-buy-perrigo-is-complicated-by-opposing-declarations.html", "keywords": [{"rank": "1", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Mylan Inc", "name": "organizations"}, {"rank": "4", "is_major": "N", "value": "Perrigo Company", "name": "organizations"}, {"rank": "5", "is_major": "N", "value": "Paulson & Co", "name": "organizations"}], "blog": [], "_id": "55ce5eac38f0d8704fb8f234", "source": "The New York Times"}